BioNTech the Lone Large Acquirer in November as Biotech Waits Clarity Post Election

Week Ending November 8th, 2024:

Biotech: 4 Transactions (2 Follow-ons, 1 PIPE, and 1 announced reverse merger) totaling just over $500 Million

Medtech: 1 Transaction (1 RD) totaling $50 Million

2024 YTD:

• 238 Biotech transactions totaling just under $43 Billion vs. 2023 YTD: 157 Biotech transactions totaling just over $23 Billion

• 117 Med Tech transactions7 Med Tech transactions totaling just under $1.8 Billion vs. 2023 YTD: 16 Med Tech transactions totaling just over $1 Billion

Private Transactions:

• Biotech: 239 US Transactions / 93 European Transactions

• Med Tech: 154 US Transactions / 51 European Transactions

November Transactions:

• BioNTech Acquired Biotheus for $800M

October Transactions:

• AbbVie Acquired Aliada Therapeutics for $1.4 Billion

• Lundbeck Acquired Longboard Pharmaceuticals for $2.6 Billion or $60/Share